| 1 |
Zidan A, Noureldin A, Kumar SA, Elsebaie A, Othman M. COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications. Semin Thromb Hemost 2023;49:9-14. [PMID: 36603593 DOI: 10.1055/s-0042-1759684] [Reference Citation Analysis]
|
| 2 |
Allas GDO, Arizala JDR, Manalo RVM. COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes. Hematol Rep 2022;14:358-72. [PMID: 36547234 DOI: 10.3390/hematolrep14040050] [Reference Citation Analysis]
|
| 3 |
Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola A, Nazy I. Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1040196] [Reference Citation Analysis]
|
| 4 |
Root-bernstein R, Huber J, Ziehl A. Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies. IJMS 2022;23:11500. [DOI: 10.3390/ijms231911500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 5 |
Kanack AJ, Padmanabhan A. Vaccine-induced immune thrombotic thrombocytopenia. Best Pract Res Clin Haematol 2022;35:101381. [PMID: 36494147 DOI: 10.1016/j.beha.2022.101381] [Reference Citation Analysis]
|
| 6 |
Rao E, Grover P, Zhang H. Thrombosis after SARS-CoV2 infection or COVID-19 vaccination: will a nonpathologic anti-PF4 antibody be a solution?—A narrative review. Journal of Bio-X Research 2022;Publish Ahead of Print. [DOI: 10.1097/jbr.0000000000000125] [Reference Citation Analysis]
|
| 7 |
Angelika W, Erika GS, Michael K, Hannes S, Ingrid P, Sabine EH, Peter Q, Oswald W, Ursula W, Katharina GP. Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers. Thromb Res 2022;218:142-4. [PMID: 36037550 DOI: 10.1016/j.thromres.2022.08.005] [Reference Citation Analysis]
|
